ASX - By Stock
|
AVR |
Re:
Ann: Application for quotation of securities - AVR
|
|
Danagram
|
1 |
534 |
3 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
1
|
534
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Agreement to Develop New Heart Valve Repair Device
|
|
Danagram
|
34 |
13K |
2 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
34
|
13K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notification regarding unquoted securities - AVR
|
|
Danagram
|
5 |
2.4K |
5 |
23/09/22 |
23/09/22 |
ASX - By Stock
|
5
|
2.4K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
A timeline going forward would be greatly appreciated
|
|
Danagram
|
138 |
53K |
3 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
138
|
53K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Proposal to Negotiate Non-Binding Letter of Intent - Merger
|
|
Danagram
|
141 |
45K |
8 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
141
|
45K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Proposal to Negotiate Non-Binding Letter of Intent - Merger
|
|
Danagram
|
141 |
45K |
0 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
141
|
45K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Proposal to Negotiate Non-Binding Letter of Intent - Merger
|
|
Danagram
|
141 |
45K |
2 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
141
|
45K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
News: AVR Anteris Technologies Says Co Has Received A Confidential, Non-Binding Proposal To...
|
|
Danagram
|
57 |
15K |
10 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
57
|
15K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
News: AVR Anteris Technologies Says Co Has Received A Confidential, Non-Binding Proposal To...
|
|
Danagram
|
57 |
15K |
7 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
57
|
15K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
News: AVR Anteris Technologies Says Co Has Received A Confidential, Non-Binding Proposal To...
|
|
Danagram
|
57 |
15K |
9 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
57
|
15K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
News: AVR Anteris Technologies Says Co Has Received A Confidential, Non-Binding Proposal To...
|
|
Danagram
|
57 |
15K |
14 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
57
|
15K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
Interview with Wayne and Proactive Investors
|
|
Danagram
|
122 |
35K |
12 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
122
|
35K
|
12
|
|
ASX - By Stock
|
AVR |
Re:
AVRO
|
|
Danagram
|
422 |
108K |
9 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
422
|
108K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
TCT DurAVR presentation Nov 21
|
|
Danagram
|
29 |
8.1K |
4 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
29
|
8.1K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Key Partnerships
|
|
Danagram
|
63 |
17K |
5 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
63
|
17K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Key Partnerships
|
|
Danagram
|
63 |
17K |
3 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
63
|
17K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Key Partnerships
|
|
Danagram
|
63 |
17K |
8 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
63
|
17K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Key Animal Study for EFS Submission Completed
|
|
Danagram
|
33 |
10K |
2 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
33
|
10K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
Danagram
|
104 |
44K |
6 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
104
|
44K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Patent Grant
|
|
Danagram
|
5 |
2.5K |
0 |
26/07/21 |
26/07/21 |
ASX - By Stock
|
5
|
2.5K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Ceasing to be a substantial holder
|
|
Danagram
|
7 |
2.7K |
0 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
7
|
2.7K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Ceasing to be a substantial holder
|
|
Danagram
|
7 |
2.7K |
2 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
7
|
2.7K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Watchthisspace tweet
|
|
Danagram
|
201 |
44K |
2 |
06/07/21 |
06/07/21 |
ASX - By Stock
|
201
|
44K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Watchthisspace tweet
|
|
Danagram
|
201 |
44K |
20 |
05/07/21 |
05/07/21 |
ASX - By Stock
|
201
|
44K
|
20
|
|
ASX - By Stock
|
AVR |
Re:
Watchthisspace tweet
|
|
Danagram
|
201 |
44K |
5 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
201
|
44K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Commentary on questions for AGM
|
|
Danagram
|
29 |
6.7K |
6 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
29
|
6.7K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Good Article in '********* Breakfast', today
|
|
Danagram
|
19 |
4.4K |
4 |
26/05/21 |
26/05/21 |
ASX - By Stock
|
19
|
4.4K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
New Research Report - MST Access
|
|
Danagram
|
16 |
6.9K |
3 |
10/05/21 |
10/05/21 |
ASX - By Stock
|
16
|
6.9K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anti-Calcification Study
|
|
Danagram
|
107 |
30K |
7 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
107
|
30K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Game plan confirmed
|
|
Danagram
|
71 |
19K |
10 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
71
|
19K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Funding Package
|
|
Danagram
|
91 |
25K |
6 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
91
|
25K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR valve patient outcomes exceed expectations
|
|
Danagram
|
65 |
17K |
4 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
65
|
17K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Aortic Vale publications form Berlin and Munich Hospitals
|
|
Danagram
|
56 |
12K |
2 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
56
|
12K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
New AVR detailed research report with valuations
|
|
Danagram
|
89 |
19K |
2 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
89
|
19K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Interview with CEO Wayne Paterson re: 2020 milestones
|
|
Danagram
|
34 |
7.4K |
19 |
07/07/20 |
07/07/20 |
ASX - By Stock
|
34
|
7.4K
|
19
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anteris Operations Update
|
|
Danagram
|
8 |
2.3K |
2 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
8
|
2.3K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
New AVR detailed research report with valuations
|
|
Danagram
|
89 |
19K |
10 |
26/06/20 |
26/06/20 |
ASX - By Stock
|
89
|
19K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
New AVR detailed research report with valuations
|
|
Danagram
|
89 |
19K |
14 |
26/06/20 |
26/06/20 |
ASX - By Stock
|
89
|
19K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Change in substantial holding
|
|
Danagram
|
31 |
8.1K |
5 |
23/06/20 |
23/06/20 |
ASX - By Stock
|
31
|
8.1K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
AVRO
|
|
Danagram
|
10 |
4.1K |
5 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
10
|
4.1K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: R&D Tax refund
|
|
Danagram
|
3 |
1.4K |
4 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
3
|
1.4K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Bioshares Research on AVR
|
|
Danagram
|
6 |
2.9K |
10 |
15/06/20 |
15/06/20 |
ASX - By Stock
|
6
|
2.9K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AGM CEO Presentation
|
|
Danagram
|
27 |
9.8K |
9 |
15/05/20 |
15/05/20 |
ASX - By Stock
|
27
|
9.8K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Consolidation/Split - AHZ
|
|
Danagram
|
108 |
1.3M |
1 |
10/03/20 |
10/03/20 |
ASX - By Stock
|
108
|
1.3M
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Proposal to be considered at EGM
|
|
Danagram
|
122 |
66K |
11 |
26/01/20 |
26/01/20 |
ASX - By Stock
|
122
|
66K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Ann: SAVR Clinical Trial
|
|
Danagram
|
72 |
39K |
15 |
22/01/20 |
22/01/20 |
ASX - By Stock
|
72
|
39K
|
15
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Update to LeMaitre Vascular deal
|
|
Danagram
|
86 |
66K |
8 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
86
|
66K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Update to LeMaitre Vascular deal
|
|
Danagram
|
86 |
66K |
1 |
12/12/19 |
12/12/19 |
ASX - By Stock
|
86
|
66K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Update to LeMaitre Vascular deal
|
|
Danagram
|
86 |
66K |
3 |
10/12/19 |
10/12/19 |
ASX - By Stock
|
86
|
66K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Leading Global TAVR Expert Says ADAPT is a GAME CHANGER!
|
|
Danagram
|
43 |
25K |
12 |
28/11/19 |
28/11/19 |
ASX - By Stock
|
43
|
25K
|
12
|
|